Checkpoint In Autoimmune Diseases – Target Approach, Challenges & Clinical Potential

Time: 3:00 pm
day: Day One


  • Learning how checkpoint agonism has the potential to counter disease pathophysiology in autoimmune conditions
  • Stressing the importance of selectivity in driving pharmacological effects
  • Identifying the right patients in the relevant diseases as a key determinant of the therapeutic success of this approach